/
DIUXF
$2.00-$0.05 (-2.44%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.67 – $2.51
39% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change+$0.62
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.4M | $13.4M | $12.7M | $13.9M | $19.5M | $23.7M | $32.2M | $38.4M |
| Cost of revenue | $3.6M | $3.1M | $3.4M | $3.4M | $5.5M | $4.0M | $3.9M | $12.8M |
| Gross profit | $6.8M | $10.3M | $9.3M | $10.6M | $14.0M | $19.7M | $28.3M | $25.7M |
| Gross margin | 65.6% | 76.7% | 73.5% | 75.8% | 72.0% | 83.2% | 87.9% | 66.8% |
| R&D | $0 | $78.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.2M | $2.1M | −$610.0K | $313.0K | $331.0K | −$3.0M | −$2.5M | −$212.0K |
| EBITDA | $1.3M | $847.6K | $178.0K | $2.1M | $3.6M | $2.4M | $2.8M | $5.6M |
| Net income | $632.3K | $398.0K | $263.0K | $561.0K | $724.0K | −$1.7M | −$1.7M | $97.0K |
| Net margin | 6.1% | 3.0% | 2.1% | 4.0% | 3.7% | -7.4% | -5.3% | 0.3% |
| EPS (diluted) | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | -0.02 | -0.02 | 0.00 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $46M | $0.01 | $0.01–$0.01 | 1 |
| 2027 | $55M | $0.04 | $0.04–$0.04 | 1 |
| 2028 | $66M | $0.08 | $0.08–$0.08 | 1 |
| 2029 | $75M | $0.13 | $0.12–$0.13 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
DIACEUTICS PLC
DIACEUTICS PLC
Held by traders on TradeandTell
No one on the platform currently holds DIUXF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in DIUXF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded DIUXF yet.